| 000 | 01812 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517125837.0 | ||
| 264 | 0 | _c20170522 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1534-6080 | ||
| 024 | 7 |
_a10.1097/TP.0000000000001590 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Smaalen, Tim C | |
| 245 | 0 | 0 |
_aPresence of Cytotoxic Extracellular Histones in Machine Perfusate of Donation After Circulatory Death Kidneys. _h[electronic resource] |
| 260 |
_bTransplantation _c04 2017 |
||
| 300 |
_ae93-e101 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 |
_aDelayed Graft Function _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aHistones _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aKidney _xchemistry |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 |
_aOrgan Preservation Solutions _xchemistry |
| 650 | 0 | 4 |
_aPerfusion _xadverse effects |
| 650 | 0 | 4 |
_aPrimary Graft Dysfunction _xetiology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aTissue Survival |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBeurskens, Daniëlle M H | |
| 700 | 1 | _aHoogland, E R Pieter | |
| 700 | 1 | _aWinkens, Bjorn | |
| 700 | 1 | _aChristiaans, Maarten H L | |
| 700 | 1 | _aReutelingsperger, Chris P | |
| 700 | 1 | _avan Heurn, L W Ernest | |
| 700 | 1 | _aNicolaes, Gerry A F | |
| 773 | 0 |
_tTransplantation _gvol. 101 _gno. 4 _gp. e93-e101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/TP.0000000000001590 _zAvailable from publisher's website |
| 999 |
_c26657285 _d26657285 |
||